Ledger.Open graph →
SEC Form D · Amendment · filed December 26, 2024

Linnaeus Therapeutics, Inc

Offering
$6.9M
Sold
$5.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HADDONFIELD, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Wesley T. Gottesman · Haddonfield, NJExec · DirectorJames T. Demetriades · Haddonfield, NJDirectorTodd T. Thomson · Haddonfield, NJDirectorChris D. Arendt · Haddonfield, NJDirectorMichael D. Poisel · Haddonfield, NJDirectorPatrick T. Mooney · Haddonfield, NJExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗